natgillin/translations-raw huggingface dataset:
Furthermore, concomitant illness, especially infections, may lead to hyperglycaemia and thereby cause an increased requirement for anti- diabetic treatment.
Spremljajoče bolezni, posebno okužbe, lahko povzročijo hiperglikemijo in zvečajo bolnikovo potrebo po zdravljenju sladkorne bolezni.
Furthermore, during the initiation of oral anticoagulant therapy it is advisable to start with a low dose and adjust this incrementally, rather than use a standard loading dose.
Boli priporočljivo je, da peroralno antikoagulantno zdravljenje začnete z majhnim odmerkom ki ga postopoma prilagajate, kot da uporabite standardni udarni odmerek.
Furthermore, Ebixa has minor or moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.
Prav tako lahko zdravilo Ebixa ima blag do zmeren vpliv na sposobnost vožnje in upravljanja s stroji, zato je potrebno bolnike opozoriti na posebno previdnost.
Furthermore, Ebixa has minor to moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.
Prav tako lahko zdravilo Ebixa ima blag ali zmeren vpliv na sposobnost vožnje in upravljanja s stroji, zato je potrebno bolnike opozoriti na posebno previdnost.
Furthermore, exfoliative skin reactions are known for dipeptidyl peptidase-4 (DPP4) inhibitors.
Poleg tega pa so eksfoliativne kožne reakcije znane za zaviralce dipeptidil-peptidaze 4 (DPP-4).
Furthermore, fesoterodine improved the mean change in the voided volume per micturition, and the mean change in the number of continent days per week (see Table 1 below).
Poleg tega je fesoterodin izboljšal srednjo vrednost spremembe izločenega urina na uriniranje in srednjo vrednost spremembe števila kontinentnih dni na teden (glejte spodnjo preglednico 1).
Furthermore, for the time-being there is no well established definition of a high risk patient although a more conservative approach is to accept at least nine T2 hyperintense lesions on the initial scan and at least one new T2 or one new
Nadalje, trenutno ne obstaja nobena dobro osnovana definicija bolnika z visokim tveganjem, čeprav bolj konzervativen pristop dovoljuje vsaj devet T2 hiperintenzivnih poškodb pri prvem pregledu in vsaj eno novo T2 ali eno novo
Furthermore, improved quality of life as measured by IBDQ was observed with infliximab.
50. tednu, poleg tega pa so pri uporabi infliksimaba opazili še izboljšanje kakovosti življenja, merjene z vprašalnikom IBDQ.
Furthermore, in a small clinical study, a subgroup of patients with creatinine clearance between 50 and 60 mL/min who received tenofovir disoproxil fumarate in combination with emtricitabine every 24 hours had a 2-4-fold higher exposure to tenofovir and worsening of renal function (see section 5.2).
Nadalje je imela v majhni klinični študiji podskupina bolnikov z očistkom kreatinina med 50 in 60 ml/min, ki je prejemala dizoproksiltenofovirijev fumarat v kombinaciji z emtricitabinom vsakih 24 ur, 2–4-krat večjo izpostavljenost tenofovirju in poslabšanje delovanja ledvic (glejte poglavje 5.2).
Furthermore, in a small clinical study, a subgroup of patients with creatinine clearance between 50 and 60 ml/min who received tenofovir disoproxil in combination with emtricitabine every 24 hours had a 2-4-fold higher exposure to tenofovir and worsening of renal function (see section 5.2).
Nadalje je imela v majhni klinični študiji podskupina bolnikov z očistkom kreatinina med 50 in 60 ml/min, ki je prejemala dizoproksiltenofovirat v kombinaciji z emtricitabinom vsakih 24 ur, 2–4- krat večjo izpostavljenost tenofovirju in poslabšanje delovanja ledvic (glejte poglavje 5.2).
Furthermore, in all three studies the rate of symptomatic VTE (symptomatic DVT, non- fatal PE, VTE-related death) was lower in rivaroxaban treated patients compared to patients treated with enoxaparin.
Delež simptomatskih VTE (simptomatske GVT, neusodne PE, smrti povezane z VTE) je bil v vseh treh kliničnih preskušanjih manjši pri bolnikih, ki so prejemali rivaroksaban v primerjavi z bolniki, ki so prejemali enoksaparin.
Furthermore, in cases of allergic dermatitis and atopic dermatitis, it is recommended to investigate and treat complicating factors, such as bacterial, fungal or parasitic infections/infestations (e.g. flea and mange).
V primeru alergijskega in atopičnega dermatitisa priporočamo, da preučite in zdravite tudi dejavnike, ki zapletajo bolezen kot so bakterijske, glivične ali parazitarne okužbe/invazije (npr. bolhe in garje).
Furthermore, in terms of exposure, the CHMP considered that the safety data available through the Lambert-Eaton myasthenic syndrome (LEMS) registry since the granting of the initial marketing authorisation were limited, as only 37 subjects recruited to the registry are on Firdapse.
Nadalje odbor CHMP glede izpostavljenosti meni, da so varnostni podatki, ki so od prve odobritve dovoljenja za promet z zdravilom na voljo v okviru registra bolnikov z Lambert-Eatonovim miastenijskim sindromom (LEMS), omejeni, saj samo 37 preiskovancev, ki so vključeni v register, prejema zdravilo Firdapse.
Furthermore, Marixino has minor to moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.
Tudi zdravilo Marixino lahko blago ali zmerno vpliva na sposobnost za vožnjo in upravljanje s stroji, zato je treba bolnike opozoriti, da morajo biti posebno previdni.
Furthermore, memantine has minor to moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.
Tudi memantin lahko blago ali zmerno vpliva na sposobnost vožnje in upravljanja s stroji, zato je potrebno bolnike opozoriti, da morajo biti posebno previdni.
Furthermore, memantine has minor to moderate influenceon the ability to drive and use machines such that outpatients should be warned to take special care.
Prav tako ima memantin majhen do zmerno velik vpliv na sposobnost vožnje in upravljanja s stroji, zato je potrebno bolnike opozoriti na posebno previdnost.
Furthermore, Memantine Merz has minor or moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.
Prav tako ima zdravilo Memantine Merz majhen do zmerno velik vpliv na sposobnost vožnje in upravljanja s stroji, zato je potrebno bolnike opozoriti na posebno previdnost.
Furthermore, Memantine Merz has minor to moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care .
Prav tako ima zdravilo Memantine Merz majhen do zmerno velik vpliv na sposobnost vožnje in upravljanja s stroji, zato je potrebno bolnike opozoriti na posebno previdnost.
Furthermore, Nemdatine has minor or moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.
Tudi zdravilo Nemdatine lahko blago ali zmerno vpliva na sposobnost za vožnjo in upravljanje s stroji, zato je treba bolnike opozoriti, da morajo biti posebno previdni.
Furthermore, Nemdatine has minor to moderate influence on the ability to drive and use machines such that outpatients should be warned to take special care.
Tudi zdravilo Nemdatine lahko blago ali zmerno vpliva na sposobnost za vožnjo in upravljanje s stroji, zato je treba bolnike opozoriti, da morajo biti posebno previdni.
Furthermore, no clinically significant renal abnormalities were noted in clinical trials.
Bolniki z okvarjenim delovanjem ledvic
Furthermore, no genotoxic effects were observed in separate non-clinical genotoxicity studies (see section 5.3).
Poleg tega v ločenih ne-kliničnih študijah genotoksičnosti niso opažali genotoksičnega delovanja (glejte poglavje 5.3).
Furthermore, patients confirmed positive for anti-drug antibodies have not shown signs of hypersensitivity or tachyphylaxis with asfotase alfa administration.
Nadalje bolniki, pri katerih so potrdili prisotnost protiteles proti zdravilu, niso kazali znakov preobčutljivosti ali tahifilaksije po dajanju astofaze alfa.
Furthermore, patients confirmed positive for antibodies have not shown signs of hypersensitivity or tachyphylaxis following subcutaneous administration of asfotase alfa.
Nadalje bolniki, pri katerih so potrdili pozitivno prisotnost protiteles proti zdravilu, niso kazali znakov preobčutljivosti ali tahifilaksije po subkutanem dajanju asfotaze alfa.
Furthermore, patients may develop antibodies against factor VIII and von Willebrand factor.
Poleg tega se lahko pri bolnikih razvijejo protitelesa proti faktorju VIII in von Willebrandovemu faktorju.
Furthermore, patients who also take other medications known to cause bradycardia or those with underlying cardiac comorbidities and/or advanced liver disease were considered to be potentially at increased risk of symptomatic bradycardia with coadministration of amiodarone, based on post-marketing reports.
Glede na poročila v obdobju trženja zdravila je poleg tega za bolnike, ki jemljejo druga zdravila, za katera je znano, da povzročajo bradikardijo, ali bolnike s srčnimi komorbidnostmi in/ali napredovano jetrno boleznijo veljalo, da pri njih lahko obstaja večje tveganje za simptomatično bradikardijo ob sočasnem dajanju amiodarona.
Furthermore, Revestive showed an acceptable safety profile for up to one year of treatment in adults.
Nadalje je zdravilo Revestive izkazalo sprejemljiv varnostni profil za obdobje do enega leta zdravljenja.
Furthermore, some of these included positive rechallenge and dechallenge.
Nadalje so nekateri od teh primerov zajemali pozitiven odziv na ponovno uporabo in prenehanje uporabe.
Furthermore, some patients who were classified as ‘off chart’ (unable to read any letters on the chart) at the beginning of the study were able to read at least one line during the eye test after treatment, and this was also considered clinically important.
Poleg tega so lahko bolniki, ki so bili na začetku študije razvrščeni kot „zunaj kartona“ (niso bili sposobni prebrati nobenih črk s kartona), prebrali vsaj eno vrstico med preverjanjem vida po zdravljenju, kar je bilo klinično pomembno.
Furthermore, the effect of CYP3A inhibitors on steady-state crizotinib exposure has not been established.
Poleg tega pa vpliv zaviralcev CYP3A na izpostavljenost krizotinibu v stanju dinamičnega ravnovesja ni bil dokazan.
Furthermore, the pharmacodynamic activity of clopidogrel was not significantly influenced by the co- administration of phenobarbital or oestrogen.
Poleg tega na farmakodinamično aktivnost klopidogrela ni pomembno vplivala sočasna uporaba fenobarbitala ali estrogena.
Furthermore, the pharmacodynamic activity of clopidogrel was not significantly influenced by the co- administration of phenobarbital or oestrogen.
Poleg tega na farmakodinamično aktivnost klopidogrela ni pomembno vplivala sočasna uporaba fenobarbitala, cimetidina ali estrogena.
Furthermore, the pharmacodynamic activity of clopidogrel was not significantly influenced by the co- administration of phenobarbital, or oestrogen.
Na farmakodinamiko klopidogrela tudi ni pomembno vplivalo sočasno jemanje fenobarbitala, ali estrogena.
Furthermore, the presence of this mutation alone did not affect the response in the INTELENCE arm.
Prisotnost samo te mutacije v kraku študije z zdravilom INTELENCE tudi ni vplivala na odziv.
Furthermore, the RMP should be updated to add viral reactivation of HBV in the severe infections described in important identified risks.
Nadalje je treba posodobiti RMP, tako da bo opis virusne reaktivacije HBV pri težkih okužbah dodan pomembnim prepoznanim tveganjem.
Furthermore, the wording on hypersensitivity in section 4.4 should be adapted.
Poleg tega pa mora ustrezno prilagoditi tudi besedilo o preobčutljivosti v poglavju 4.4.
Furthermore, there is evidence of an association between hypocalcaemia and secondary neurological events reported in these cases including; seizures, numbness and tetany (see section 4.4).
Poleg tega obstajajo dokazi o povezanosti hipokalciemije in posledičnih nevroloških dogodkov, o katerih so poročali v teh primerih in so vključevali napade krčev, otrplost in tetanijo (glejte poglavje 4.4).
Furthermore, two 12- week, placebo-controlled studies were conducted in patients with inadequately controlled type 2 diabetes and hypertension.
Poleg tega sta bili pri bolnikih z neustrezno urejeno sladkorno boleznijo tipa 2 in hipertenzijo opravljeni dve 12-tedenski, s placebom kontrolirani študiji.
Furthermore, Vision blurred is listed as an additional ADR associated with the timolol component of Ganfort in the CCDS.
Zamegljen vid je prav tako v CCDS naveden kot dodatni neželeni učinek, povezan z zdravilno učinkovino timolol, ki je sestavina zdravila Ganfort.
Furthermore, vortioxetine, in the dose range of 5-20 mg/day, demonstrated efficacy on the broad range of depressive symptoms (assessed by improvement in all MADRS single–item scores).
Poleg tega je vortioksetin, v razponu odmerkov od 5 do 20 mg/dan, dokazal učinkovitost pri najrazličnejših depresivnih simptomih (ocenjeno z izboljšanjem vseh točk v posamičnih postavkah po lestvici MADRS).
fusariosis (fungal infection caused by Fusarium),
fuzarioze (vrste glivične okužbe, ki jo povzroča Fusarium),
Fusarium spp.: 11 of 24 patients who had proven or probable fusariosis were successfully treated with posaconazole 800 mg/day in divided doses for a median of 124 days and up to 212 days.
Fusarium spp.: 11 od 24 bolnikov, ki so dokazano ali verjetno imeli fusariozo, so uspešno pozdravili posakonazolom 800 mg/dan v deljenih odmerkih, ki so jih dajali mediano vrednost časa 124 dni ter do 212 dni.
Fusarium spp.: Seven (3 complete, 4 partial responses) of 17 patients were successfully treated with voriconazole.
Fusarium spp.: Sedem (3 popolni, 4 delni odzivi) od 17 bolnikov je bilo uspešno zdravljenih z vorikonazolom.
Fusarium spp.: Seven (3 complete,4 partial responses) of 17 patients were successfully treated with voriconazole.
Fusarium spp.: Sedem (3 popolni, 4 delni odzivi) od 17 bolnikov je bilo uspešno zdravljenih z vorikonazolom.
Fusidic acid
fenitoin
fusidic acid
fusidna kislina
Fusidic acid (saquinavir/ritonavir)
fusidna kislina (sakvinavir/ritonavir)
fusidic acid (used to treat bacterial infections); sildenafil if you suffer from a lung disease called pulmonary arterial hypertension that makes breathing difficult.
fusidno kislino (uporablja se za zdravljenje bakterijskih okužb), sildenafil, če imate pljučno bolezen, ki jo imenujemo pljučna arterijska hipertenzija, ki oteži dihanje.
fusidic acid - an antibiotic used to treat infections
fusidno kislino – antibiotik, ki se uporablja za zdravljenje okužb
fusidic acid in osteo-articular infections is not recommended (see section 4.5);
fusidno kislino pri osteoartikularnih okužbah ni priporočljiva (glejte poglavje 4.5);
fusidic acid used to treat long-term infections of the bones and joints (e.g. osteomyelitis);
fusidno kislino za zdravljenje dolgotrajnih okužb kosti in sklepov (npr. osteomielitisa);
Fusidic acid used to treat long-term infections of the bones and joints may be taken under doctor’s supervision (see Other medicines and Kaletra section); colchicine (used to treat gout) if you have kidney and/or liver problems (see the section on
Fusidno kislino za zdravljenje dolgotrajnih okužb kosti in sklepov se sme uporabljati pod nadzorstvom zdravnika (glejte poglavje Druga zdravila in zdravilo Kaletra); kolhicin (zdravilo za zdravljenje protina) – če imate težave z ledvicami in/ali jetri (glejte poglavje
Fusidic acid used to treat long-term infections of the bones and joints may be taken under doctor’s supervision (see Other medicines and Lopinavir/Ritonavir Mylan section);
Fusidno kislino za zdravljenje dolgotrajnih okužb kosti in sklepov se sme uporabljati pod nadzorom zdravnika (glejte poglavje Druga zdravila in zdravilo Lopinavir/ritonavir Mylan);
Fusidic acid:
dan, večkratni odmerek)
Fusidic acid:
fenitoin:
Fusidic acid: do not take fusidic acid (a medicine for bacterial infections) while using this medicine.
povzročajo bakterije, s fusidno kislino: dokler uporabljate to zdravilo, ne jemljite fusidne kisline (zdravila za bakterijske okužbe).
Fusion inhibitor
Zaviralec fuzije
Fusion inhibitors
Fuzijski zaviralci (zaviralci zlitja)
Fusion Inhibitors
Zaviralci fuzije
FUSION was a randomised, double-blinded study that evaluated 12 or 16 weeks of treatment with sofosbuvir and ribavirin in subjects who did not achieve SVR with prior interferon-based treatment (relapsers and nonresponders).
Študija FUSION je bila randomizirana, dvojno slepa študija, v kateri so ocenili 12- ali 16-tedensko zdravljenje s sofosbuvirjem in ribavirinom pri osebah, ki niso dosegle SVR s predhodnim zdravljenjem na podlagi interferona (osebe z relapsom ali neodzivne osebe).
Fusobacterium species* Peptostreptococcus species* Porphyromonas asaccharolytica* Prevotella species*
Porphyromonas asaccharolytica* vrste Prevotella
Futher dilution of the appropriate volume of the concentrate with either sodium chloride 9 mg/ml (0.9%) solution for injection or glucose 50 mg/ml (5%) solution for injection to reach a final topotecan concentration of between 25 and 50 microgram/ml in the solution for infusion.
Ustrezen volumen koncentrata se redči z 9 mg/ml (0,9 %) injekcijsko raztopino natrijevega klorida ali 50 mg/ml (5 %) injekcijsko raztopino glukoze, da se doseže končno koncentracijo topotekana v raztopini za infundiranje med 25 in 50 mikrogrami/ml.
Futher dilution of the appropriate volume of the concentrate with either sodium chloride 9 mg/ml (0.9%) solution for injection or glucose 50 mg/ml (5%) solution for injection to reach a final topotecan concentration of between 25 and 50 microgram/ml in the solution for infusion.
Ustrezno količino tako pripravljene raztopine morate še dodatno razredčiti z 9 mg/ml (0,9 %) raztopino natrijevega klorida za injiciranje ali s 50 mg/ml (5 %) raztopino glukoze za injiciranje, da nastane končni pripravek s koncentracijo med 25 in 50 mikrogramov/ml.
FUTURE 1 was an open-label, uncontrolled study that was conducted with the dispersible tablet formulation of bosentan administered at a maintenance dose of 4 mg/kg twice daily to 36 patients from 2 to 11 years of age.
FUTURE 1 je bila odprta, nenadzorovana študija, ki so jo izvajali z bosentanom v obliki disperzibilnih tablet v vzdrževalnem odmerku 4mg/kg dvakrat dnevno, ki so ga dajali 36 bolnikom, starim od 2 do 11 let.
Future dose adjustments are based on changes in platelet counts only and made in 1 µg/kg increments (see table below).
Nadaljnje prilagoditve odmerka morajo temeljiti zgolj na spremembi števila trombocitov in jih je treba izvajati v korakih po 1 µg/kg (glejte preglednico spodaj).
Future laying hens and breeders should get a second vaccination 4-6 weeks after first vaccination
Pri bodočih nesnicah in matičnih jatah moramo cepljenje ponoviti 4 do 6 tednov po prvem cepljenju.
Future laying hens and breeders: administer a second 0.5 ml dose 4-6 weeks after the first vaccination.
Pri bodočih nesnicah in matičnih jatah:dajte drugi odmerek 0,5 ml 4 do 6 tednov po prvem cepljenju.
Fuzeon 90 mg/ml powder and solvent for solution for injection
Fuzeon 90 mg/ml prašek in vehikel za raztopino za injiciranje
Fuzeon 90 mg/ml powder and solvent for solution for injection Enfuvirtide
Fuzeon 90 mg/ml prašek in vehikel za raztopino za injiciranje enfuvirtid
Fuzeon 90 mg/ml powder for solution for injection Enfuvirtide
Fuzeon 90 mg/ml prašek za raztopino za injiciranje enfuvirtid
Fuzeon contains less than 1 mmol sodium (23 mg) per dose, i.e. it is essentially ‘sodium-free’.
Zdravilo Fuzeon vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija’.
Fuzeon contains sodium
Zdravilo Fuzeon vsebuje natrij
Fuzeon contains the active substance enfuvirtide and belongs to a group of medicines called ‘antiretrovirals’.
Zdravilo Fuzeon vsebuje učinkovino enfuvirtid in spada v skupino zdravil, ki se imenujejo protiretrovirusna zdravila.
Fuzeon has been shown not to interact with your other anti-HIV medicines or rifampicin (an antibiotic).
Za zdravilo Fuzeon so dokazali, da medsebojno ne deluje z vašimi drugimi zdravili proti HIV ali z rifampicinom (antibiotik).
Fuzeon has not been tested for its effect on your ability to drive a car or use tools or machines.
Možnih učinkov zdravila Fuzeon na vašo sposobnost vožnje avtomobila ali uporabe orodij oziroma upravljanja strojev niso preskušali.
Fuzeon is given as a 1 ml injection just below the skin – called a ‘subcutaneous’ injection.
Zdravilo Fuzeon dajemo kot 1-ml injekcijo tik pod kožo – imenujemo jo < subkutana< injekcija.
Fuzeon is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected patients who have received treatment with and failed on regimens containing at least one medicinal product from each of the following antiretroviral classes: protease inhibitors, non- nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors, or who have intolerance to previous antiretroviral regimens (see section 5.1).
Zdravilo Fuzeon je v kombinaciji z drugimi protiretrovirusnimi zdravili indicirano za zdravljenje bolnikov, okuženih s HIV-1, in neuspešno zdravljenih z režimi zdravljenja, ki so vsebovali vsaj eno od zdravil iz vsakega od naslednjih protiretrovirusnih razredov: zaviralcev proteaz, nenukleozidnih zaviralcev reverzne transkriptaze in nukleozidnih zaviralcev reverzne transkriptaze, ali bolnikov, ki prejšnjih protiretrovirusnih režimov zdravljenja ne prenašajo (glejte poglavje 5.1).
Fuzeon is not a cure for HIV infection.
Fuzeon ni zdravilo za ozdravitev okužbe s HIV.
Fuzeon is used for the treatment of Human Immune deficiency Virus (HIV) - in combination with other antiretroviral medicines in patients infected with HIV.
Zdravilo Fuzeon uporabljamo za zdravljenje virusa humane imunske pomanjkljivosti (HIV) – v kombinaciji z drugimi protiretrovirusnimi zdravili pri bolnikih, ki so okuženi z virusom HIV.
Fuzeon must be given as an injection just below the skin – called a ‘subcutaneous’ injection.
Zdravilo Fuzeon je treba dati kot injekcijo tik pod kožo – < subkutana< injekcija.
Fuzeon must be taken as part of a combination regimen.
Zdravilo Fuzeon je treba jemati kot del kombiniranega režima zdravljenja.
Fuzeon powder and solvent for solution for injection comes in a carton containing: 60 vials of Fuzeon
Prašek in vehikel za raztopino za injiciranje zdravila Fuzeon sta v škatli, ki vsebuje: 60 vial zdravila Fuzeon,
FUZEON VIAL LABEL
NALEPKA NA VIALI FUZEONA
Fuzeon was originally authorised under ‘Exceptional Circumstances’, because for scientific reasons it had not been possible to obtain complete information on the medicine.
Zdravilo Fuzeon je bilo prvotno odobreno v „izjemnih okoliščinah“, ker zaradi znanstvenih razlogov ni bilo mogoče pridobiti vseh informacij o zdravilu Fuzeon.
Fuzeon+OB regimen Per 100 patient years
na 100 bolnikovih let
FVIII activity in plasma is expressed either as a percentage (relative to normal human plasma) or in IU (relative to an International Standard for FVIII in plasma).
Aktivnost F VIII v plazmi je izražena bodisi kot odstotek (glede na normalno humano plazmo) bodisi v i.e. (glede na Mednarodni standard za količino FVIII v plazmi).
FVIII activity in plasma is expressed either as a percentage (relative to normal human plasma) or in IU (relative to an International Standard for FVIII in plasma).
Aktivnost FVIII v plazmi je izražena bodisi kot odstotek (glede na normalno humano plazmo) bodisi v i.e. (glede na Mednarodni standard za količino FVIII v plazmi).
FVIII inhibition: Patients with haemophilia A may develop neutralising antibodies (inhibitors) to FVIII.
Inhibicija FVIII: Bolniki s hemofilijo A lahko zelo redko razvijejo nevtralizirajoča protitelesa (inhibitorje) proti FVIII.
FVIII level required (% or IU/dl)
Potrebna raven FVIII (% ali i.e./dl)
FVIII/VWF inhibition: the medicine stops working properly (continuous bleeding).
Inhibicija FVIII/VWF: Zdravilo preneha delovati pravilno (vztrajna krvavitev).
Fycompa 0.5 mg/ml oral suspension is a white to off-white suspension.
Fycompa 0,5 mg/ml peroralna suspenzija je bela do belkasta suspenzija.
Fycompa 0.5 mg/ml oral suspension perampanel
Fycompa 0,5 mg/ml peroralna suspenzija perampanel